RE: Ovb 4p buy coming?10 Nov 2022 20:43
The market is huge, not massive but huge but more importantly is the ratio. I mean you could have a multi billion pounds market but only get 0.1% of it. The difference with women's libido is it's apparently 10% of population 20-50 ish so the numbers could be massive. It's already approved in Russia
"Minzdrav has approved the medical prescription of Orenetide, administered through a nasal spray, to patients in the Russian Federation under the trade name 'Desirix' for the treatment of HSDD, a condition characterized by a distressing lack or loss of sexual desire. The MA was approved based on data from two Phase 1 studies, a Phase 2a study and the pivotal Phase 3 study completed in 2019, conducted in Russia, which established the safety and efficacy of Orenetide.
The approved manufacturing site for Orenetide will be operated by two reputable pharmaceutical manufacturers - Nativa and OncoTarget, with commercial production of Orenetide expected to start in Spring 2022. Ovoca Bio is currently in discussions with a number of partners to explore a potential license partnerships for sales of Orenetide on the Russian market"